There Should Be a Price to Pay for Knowingly Lying to Consumers
Why TINA.org wants the Supreme Court to address proof of harm in Lanham Act cases.
ARMRA Colostrum
Case Name (Date)
Petros et al. v. Rahal Biosciences, Inc.
24-cv-3182, S.D.N.Y.
(April 2024)
Product/Service
ARMRA Colostrum dietary supplements
Allegations
Falsely marketing products as “research-backed” to provide various health benefits – including “strengthen[ing] immunity,” “fortify[ing] gut health,” and “activat[ing] hair growth” – without adequate scientific evidence to support such claims
Failing to include mandated disclaimers with disease treatment claims, in violation of FDA regulations
Status
Voluntarily dismissed When a complaint is dismissed with prejudice, it cannot be refiled.
The Latest
TINA.org Action Sheds Light on SunPowerLED’s False Endorsement Claims
Letters alert agencies and organizations to company’s improper marketing.
VIN History USA’s ‘Free’ VIN Report
TINA.org discovers some roadblocks to unlocking this purportedly free offer.
Amica Insurance: Back To Zero
Recent ad shows what it takes to make a comeback.
Will the MLM Industry Fix Its Earnings Claims Problem?
New research points to “no.”